Criteria for the definitive diagnosis of melanoma, by creation of a scorecard

S. A Yargunin; I. S Davidenko

doi:10.17816/onco40011

Russian Journal of Oncology ›› 2013, Vol. 18 ›› Issue (3) : 49 -52. DOI: 10.17816/onco40011

Articles

research-article

Criteria for the definitive diagnosis of melanoma, by creation of a scorecard

Author information +

History +

PDF

Abstract

Melanoma of a skin is thought to be one of the most aggressive tumors with unpredictable prognosis because of a high potency of local growth, local and remote metastases, and dissemination. Regarding this point very important aspect is an adequate assessment of patients and proper therapy administration according to a disease stage. Options for effective diagnosis is to create a single user registration card will allow to create the uniform Russian Federation register of patients with a skin melanoma and will help to introduce an international treatment standard with distribution of patients on stages and substages.

Keywords

melanoma of a skin / morfo-statistical assessment / early diagnostics / malignant neoplasms

Cite this article

Download citation ▾

S. A Yargunin, I. S Davidenko. Criteria for the definitive diagnosis of melanoma, by creation of a scorecard. Russian Journal of Oncology, 2013, 18(3): 49-52 DOI:10.17816/onco40011

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2007 г Вестник РОНЦ им. Н.Н. Блохина. 2009; 20( 3): 2.

[2]	Мерабишвили В.М., Чепик О. Ф. Анализ выживаемости и погодичной летальности больных злокачественной меланомой кожи на популяционном уровне. Вопросы онкологии. 2006; 52 (4): 385-91.

[3]	Allen D.C. Histopathology reporting. 2-nd Ed. ; 2006: 200-9.

[4]	Balch C.M. Cutaneous melanoma: prognosis and treatment results worldwide. Semin. Surg. Oncol. 1992; 8: 400-14.

[5]	Balch C.M., SoongS.J., Murad T.M. et al. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann. Surg. 1981; 193: 377-88.

[6]	Batistatou A., Cook M.G., Massi D. Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology. Virchows Arch. 2009; 454 (5): 505-11.

[7]	Buzaid A.C., Ross M.I., Balch C.M. et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J. Clin. Oncol. 1997; 15: 1039-51.

[8]	Carli P. et al. Campagna per la diagnosis precode del melanoma. Quanto e efficace lazione di ''filtro'' del medico di famiglia? G. Ital. Dermatol. Venereol. 1998; 133( 6): 405-10.

[9]	Clark W.H., Elder D.E., Guerry D. et al. Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst. 1989; 81: 1893-904.

[10]	Compton C.C., Barbill R., Wick M.R., Balch C. Protocol for the examination of specimen from patients with melanoma of the skin. Arch. Pathol. Lab. Med. 2003; 127: 1253-60.